Clinical trial
Paclitaxel in Treating Patients With Lung Cancer
NCT00002972 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002972 |
|---|---|
| Title | Paclitaxel in Treating Patients With Lung Cancer |
| Official title | Phase II Study on TAXOL in Bronchioalveolar Carcinoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Enrollment | 25 |
| Start date | Jan 1, 1997 |
| Primary completion | Aug 1, 2002 |
| First posted | Apr 17, 2003 |
| Last update posted | Jul 2, 2012 |
| Countries | Belgium, Czechia, Germany, Italy, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: